171 – 180 of 309
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
(
- Contribution to journal › Article
-
Mark
Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid in Alzheimer's : A precious tool
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article
-
Mark
Preclinical amyloid-β and axonal degeneration pathology in delirium
(
- Contribution to journal › Article
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
(
- Contribution to journal › Article